Takeda Loses 5th Actos Bladder Cancer Lawsuit with $3.6M Verdict

Takeda Loses 5th Actos Bladder Cancer Lawsuit with $3.6M Verdict

The fifth Actos bladder cancer lawsuit to make its way through trial has resulted in another notable loss for Takeda Pharmaceuticals Co. – and a huge victory for plaintiffs, as a Philadelphia jury has recently awarded the plaintiff in this case $3.6 million in damages.

In the latest Actos bladder cancer lawsuit to go to trial, Takeda has been handed another defeat, as the jury awarded the plaintiff a $3.6M verdict.

In the latest Actos bladder cancer lawsuit to go to trial, Takeda has been handed another defeat, as the jury awarded the plaintiff a $3.6M verdict.

This case, Kristufek v. Takeda Pharmaceuticals America Inc., Philadelphia Court of Common Pleas, was sent to the jury for deliberation last week.

After a few days of deliberating, the jurors came back with a ruling in favor of the plaintiff, a former teacher who developed Actos bladder cancer, awarding him:

  • $300,000 as compensation for his medical bills
  • $2 million as compensation for his pain and suffering (related to his development of bladder cancer)
  • $1.3 million in punitive damages, which were intended to punish Takeda for its “reckless indifference” in testing the safety of Actos before bringing it to market and failing to warn the public about the serious risks associated with Actos use.

What the Verdict in this Actos Bladder Cancer Lawsuit May Mean: The Big Picture

Given that this Actos bladder cancer lawsuit is still among the handful of the initial cases to go through trial, the verdict in this case could end up having a far bigger impact on the ongoing Actos bladder cancer litigation still pending against Takeda. In fact, to give you some perspective on the nature of the ongoing Actos bladder cancer litigation, there are still:

  • About 3,500 Actos bladder cancer lawsuits pending in the Louisiana-based multidistrict litigation (MDL No. 2299), where these cases have been consolidated to facilitate the pre-trial proceedings
  • About 4,500 more Actos bladder cancer lawsuits pending in state courts throughout the U.S.

While the next Actos bladder cancer lawsuit that Takeda will face in court is scheduled to get underway in March, it will in interesting to see if the strong possibility of punitive damages may end up driving Takeda to try to settle some – if not the majority – of these pending cases prior to trial.

As more news about this ongoing litigation becomes available, we’ll bring you the latest details here.

Phoenix Dangerous Drug Lawyer at the Law Office of Richard Langerman

Have you been diagnosed with bladder cancer after taking the diabetes drug Actos? Or have you been hurt after taking any dangerous or defective medication? If so, you can turn to the Phoenix dangerous drug lawyer at the Law Office of Richard Langerman for aggressive legal advocacy and help standing up to negligent drug makers. When you trust your case in the hands our skilled attorney, you can trust that he will fight to help you obtain the maximum possible compensation to which you are entitled.

Call us today at (602) 240-5525 to learn more about your rights and receive professional advice regarding your case by setting up a free, no obligations initial consult with our trusted attorneys.

From our offices in Phoenix, we provide superior legal services and representation to clients throughout the state of Arizona.

No Comments

Sorry, the comment form is closed at this time.